194 related articles for article (PubMed ID: 31002579)
1. Advanced Epithelial Ovarian Cancer: Do More Options Mean Greater Benefits?
Bouberhan S; Shea M; Cannistra SA
J Clin Oncol; 2019 Jun; 37(16):1359-1364. PubMed ID: 31002579
[No Abstract] [Full Text] [Related]
2. Surgical technique of en bloc pelvic resection for advanced ovarian cancer.
Chang SJ; Bristow RE
J Gynecol Oncol; 2015 Apr; 26(2):155. PubMed ID: 25872895
[TBL] [Abstract][Full Text] [Related]
3. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
Kim HS; Bristow RE; Chang SJ
Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
[TBL] [Abstract][Full Text] [Related]
4. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
Khatib G; Guzel AB; Gulec UK; Vardar MA
Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
[TBL] [Abstract][Full Text] [Related]
5. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
Goodman KA
J Clin Oncol; 2016 Nov; 34(31):3724-3728. PubMed ID: 27601550
[TBL] [Abstract][Full Text] [Related]
6. External Beam, Brachytherapy, or Chemotherapy? Defining Adjuvant Therapy for Early-Stage and High- and High-Intermediate-Risk Endometrial Cancer.
Jang JW; Lee LJ
J Clin Oncol; 2019 Jul; 37(21):1778-1784. PubMed ID: 31163010
[No Abstract] [Full Text] [Related]
7. Laparoscopic Resection of a High Grade Serous Ovarian Cancer that Recurred at the Vaginal Stump with Extensive Pelvic Adhesions after Complete Surgical Staging.
Li J; Duan J; Mao R; Jiang W
J Minim Invasive Gynecol; 2022 Mar; 29(3):343-344. PubMed ID: 34871772
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
10. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
Kollmannsberger CK; Nappi L; Nichols C
J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
[No Abstract] [Full Text] [Related]
11. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
12. A Way to Reduce the Occurrence of Intraoperative Capsule Rupture in Presumed Clinically Early-stage Ovarian Cancer with Adhesions to the Abdominal Wall.
Li J; Duan J; Mao R; Jiang W
J Minim Invasive Gynecol; 2022 Jan; 29(1):16. PubMed ID: 34265440
[TBL] [Abstract][Full Text] [Related]
13. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
14. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
[TBL] [Abstract][Full Text] [Related]
15. Treatment Approaches for Platinum-Resistant Ovarian Cancer.
St Laurent J; Liu JF
J Clin Oncol; 2024 Jan; 42(2):127-133. PubMed ID: 37910841
[No Abstract] [Full Text] [Related]
16. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
17. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
18. Colon resection for ovarian cancer: intraoperative decisions.
Hoffman MS; Zervose E
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
[TBL] [Abstract][Full Text] [Related]
19. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
Zighelboim I; Broaddus R; Ramirez PT
Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?
Mehta MP; Kotecha R
J Clin Oncol; 2018 Oct; ():JCO2018793232. PubMed ID: 30296192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
